Steven Idell Selected Research

monoamine-sulfating phenol sulfotransferase

3/2011	Sulfation of chlorotyrosine and nitrotyrosine by human lung endothelial and epithelial cells: role of the human SULT1A3.
1/2007	Generation and release of nitrotyrosine O-sulfate by HepG2 human hepatoma cells upon SIN-1 stimulation: identification of SULT1A3 as the enzyme responsible.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven Idell Research Topics

Disease

18	Lung Injury 01/2022 - 05/2003
18	Inflammation (Inflammations) 10/2021 - 01/2002
17	Fibrosis (Cirrhosis) 04/2022 - 04/2003
14	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022 - 04/2003
14	Acute Lung Injury 08/2018 - 01/2002
13	Empyema 01/2022 - 11/2004
11	Infections 01/2022 - 02/2009
9	Neoplasms (Cancer) 12/2015 - 08/2002
8	Pneumonia (Pneumonitis) 01/2022 - 08/2002
6	Sepsis (Septicemia) 05/2017 - 01/2002
5	Hemorrhage 01/2021 - 04/2015
4	Pleural Effusion (Pleural Effusions) 02/2021 - 02/2012
4	Wounds and Injuries (Trauma) 01/2020 - 05/2003
4	Malignant Mesothelioma 07/2013 - 06/2010
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2012 - 01/2002
4	Carcinoma (Carcinomatosis) 07/2008 - 07/2004
3	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2014
3	Pleurisy (Pleuritis) 01/2021 - 10/2002
3	Edema (Dropsy) 07/2011 - 01/2006
2	COVID-19 01/2021 - 09/2020
2	Dyspnea (Shortness of Breath) 01/2021 - 09/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 01/2014
2	Thrombosis (Thrombus) 07/2013 - 03/2006
2	Mesothelioma 07/2013 - 09/2010
2	Human Influenza (Influenza) 01/2012 - 07/2011
2	Weight Loss (Weight Reduction) 01/2012 - 07/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2008 - 01/2004
2	Hepatocellular Carcinoma (Hepatoma) 05/2007 - 01/2007
2	Renal Insufficiency (Renal Failure) 01/2006 - 05/2003
2	Pulmonary Edema 06/2003 - 05/2003
1	Obesity 01/2022
1	Cicatrix (Scar) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Mycobacterium avium-intracellulare Infection 01/2022
1	Pain (Aches) 01/2020

Drug/Important Bio-Agent (IBA)

20	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2021 - 10/2002
19	FibrinIBA 01/2022 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2004
14	Plasminogen Activator Inhibitor 1IBA 01/2021 - 05/2003
11	Plasminogen Activators (Plasminogen Activator)IBA 02/2021 - 04/2003
9	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2013
7	Biomarkers (Surrogate Marker)IBA 02/2021 - 03/2011
7	Messenger RNA (mRNA)IBA 07/2013 - 01/2004
6	SmokeIBA 08/2018 - 05/2007
5	CollagenIBA 04/2022 - 02/2012
5	CytokinesIBA 01/2022 - 06/2003
5	Phosphotransferases (Kinase)IBA 01/2021 - 01/2014
5	Thromboplastin (Tissue Factor)IBA 02/2016 - 05/2003
5	Peptide Hydrolases (Proteases)FDA Link 06/2015 - 08/2002
4	SootIBA 01/2022 - 02/2014
4	AnticoagulantsIBA 06/2018 - 01/2002
4	Urokinase Plasminogen Activator ReceptorsIBA 06/2010 - 05/2003
3	caveolin-1 (82-101)IBA 03/2022 - 01/2015
3	fibrin fragment D (D-dimer)IBA 01/2021 - 10/2009
3	Fibrinolysin FDA Link 01/2021 - 05/2003
3	Thrombin FDA Link 01/2021 - 03/2006
3	Protein CIBA 01/2017 - 05/2002
3	Tetracycline (Achromycin)FDA LinkGeneric 04/2015 - 10/2002
3	Carrier Proteins (Binding Protein)IBA 07/2008 - 01/2004
2	indium-bleomycinIBA 01/2022 - 12/2019
2	CalponinsIBA 01/2022 - 01/2019
2	Oxygen (Dioxygen)IBA 10/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2020
2	activated protein C receptorIBA 01/2021 - 07/2013
2	BilirubinIBA 01/2021 - 09/2020
2	Peptides (Polypeptides)IBA 12/2019 - 02/2018
2	InterferonsIBA 01/2019 - 12/2016
2	Superoxides (Superoxide)IBA 01/2019 - 01/2016
2	EnzymesIBA 08/2018 - 01/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2018 - 06/2018
2	Surface-Active Agents (Surfactants)IBA 01/2017 - 12/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 01/2006
2	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2016 - 12/2015
2	PlasminogenIBA 01/2016 - 05/2003
2	AntigensIBA 01/2015 - 01/2012
2	Factor X (Stuart Factor)IBA 02/2012 - 01/2006
2	3-nitrotyrosineIBA 03/2011 - 01/2007
2	monoamine-sulfating phenol sulfotransferaseIBA 03/2011 - 01/2007
2	Tyrosine (L-Tyrosine)FDA Link 03/2011 - 01/2004
2	Sulfates (Sulfates, Inorganic)IBA 05/2007 - 01/2007
2	Factor VIIa (Activated Factor VII)IBA 01/2006 - 05/2003
2	AsbestosIBA 11/2004 - 01/2004
1	Fibronectins (Fibronectin)IBA 04/2022
1	FructoseIBA 01/2022
1	CateninsIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Z-Form DNA (Z-DNA)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	NitrogenIBA 01/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2003
6	Thrombolytic Therapy 01/2021 - 06/2013
2	Pleurodesis 07/2008 - 03/2006
1	Contraindications 01/2021